Dr Sean Lal

BMedSci(Hons), MBBS(Hons), MPhil(Med), PhD(Med), FRACP

School of Medical Sciences, Sydney Medical School and Royal Prince Alfred Hospital

Telephone 9351 3209

Map

Biographical details

Dr Sean Lal is a Clinical Academic Cardiologist at the University of Sydney and Royal Prince Alfred Hospital. He completed his undergraduate degree in Medical Science with first class honours at the University of Sydney, receiving full academic scholarship. He pursued his graduate Medical Degree (MBBS) and a Master of Medicine by research (MPhil) at the University of Sydney, where he was awarded the Dean's Scholarship, the Medical Foundation Scholarship and the University of Sydney Bercovici Medal. As a medical doctor, Sean completed all of his general and specialty clinical training at Royal Prince Alfred Hospital. During his cardiology training, he was awarded a National Churchill Fellowship to study mechanisms of cardiac regeneration at Harvard Medical School.

Sean has a clinical and research interest in heart failure. For his PhD in this field, he was awarded a combined National Health and Medical Research Council (NHMRC) and National Heart Foundation (NHF) Scholarship, as well as the NHMRC and Royal Australasian College of Physicians (RACP) scholarship for research excellence.

He was also awarded a Commonwealth Endeavour Postgraduate Fellowship to Harvard University and Massachusetts Institute of Technology (MIT), where he undertook proof of concept studies demonstrating the intrinsic regenerative capacity of the human heart following myocardial infarction.

Sean is Block Chair for Cardiovascular Medicine. He is also a Lecturer in Visceral Anatomy and the Course Coordinator for Cardiac, Endocrine, Abdominal, Pelvic and Renal Anatomy for the Sydney Medical (MD) Program. He is also the Course Coordinator for ANAT2011 in the Faculty of Science.

Sean is a Co-Director of the Sydney Heart Bank and the Head of the Cardiac Research Laboratory in the School of Medical Sciences, which focuses on basic science and translational research into human heart failure. He is also the Theme Leader for Cardiovascular Research in the Bosch Institute, Sydney Medical School.

In a collaboration with Dr John O'Sullivan from the Charles Perkins Centre, Sean and John have established the Precision Cardiovascular Laboratory, which aims to correlate serum biomarkers of cardiovascular disease with pathogenic and age-related changes in human heart tissue via integration of the cardiac genome, transcriptome, metabolome and proteome.

Research interests

Our translational research focuses on the human heart. We aim to investigate the molecular basis of cardiomyopathies, cellular changes in ageing, and intrinsic mechanisms of cardiac regeneration.

We uniquely draw on tissue from The Sydney Heart Bank (SHB), which contains over 20,000 cryopreserved human cardiac samples from our collaborations with St Vincent's Hospital (Sydney), the Australian Red Cross Donor Service and Royal Prince Alfred Hospital.

We have developed an extensive tissue database and international research network with the common goal to further our understanding of human heart failure.

Current projects

Sydney Heart Bank

Overview

In 1989, in collaboration with the late Dr. Victor Chang, Prof. dos Remedios established the Sydney Heart Bank to collect and store explanted human hearts for research purposes. The Sydney Heart Bank (SHB) now comprises of over 20,000 human cardiac samples from 400+ explanted failing hearts and 100+ donor hearts. Currently, we collaborate with the Heart/Lung Transplant Unit at St Vincent's Hospital (Sydney) and Royal Prince Alfred Hospital.

The Sydney Heart Bank shares its collection of samples with over 30 research laboratories within Australia and around the world (listed below). We coordinate these independent external research projects with our own in-house projects. These range from examining cardiac regeneration, contractile mechanics cellular and molecular cardiology, cardiac proteomics, vascular diseases, and aortopathies.

Collaborators

Research laboratories we currently collaborate with

Australia

  • Westmead Millennium Institute, NSW
  • Westmead Hospital, NSW
  • Discipline of Pathology, University of Sydney
  • Victor Chang Cardiac Research Institute, NSW
  • University of Newcastle, NSW
  • Australian National University, Canberra
  • University of Queensland, QLD
  • Baker IDI Heart & Diabetes Research Institute, VIC
  • Murdoch Children’s Research Institute, VIC
  • Monash University, VIC
  • Federation University Australia, VIC
  • University of Western Australia

Europe

  • Imperial College London, UK
  • Kings College London, UK
  • St. Georges University London
  • VU Medical Centre, Amsterdam, The Netherlands
  • University of Amsterdam, The Netherlands
  • University Medical Center Utrecht, The Netherlands
  • Ruhr University, Bochum, Germany
  • Karolinska Institute, Sweden
  • Uppsala University, Sweden

New Zealand

  • University of Auckland
  • University of Otago

Asia

  • Waseda University, Tokyo
  • National Technological University, Singapore

Canada

  • University of Ontario

United States

  • Mayo Clinic
  • University of Kentucky
  • Johns Hopkins University
  • University of Maryland
  • Harvard Medical School
  • Children’s Hospital Boston
  • University of Pittsburgh
  • University South Carolina
  • Loyola University Chicago
  • University of Minnesota
  • University of Vermont

Executive & Scientific Review Board

Executive & Managing Committee

  • Professor Cris dos Remedios, Dr Sean Lal, Dr Amy Li

Scientific Review Board

Chair: Professor David Allen

Basic Science Members

  • Professor Anne Keogh
  • Professor Paul Allen
  • Professor Roger Cooke

Clinical Science Members

  • Dr. Tim Cartmill
  • Dr. Alan Farnsworth
  • Professor Paul Bannon

Types of Hearts in the SHB

  • Ischaemic Cardiomyopathy
  • Dilated Cardiomyopathy
  • Hypertrophic Cardiomyopathy
  • Restrictive Cardiomyopathy
  • Alcohol induced Cardiomyopathy
  • Virus induced Cardiomyopathy
  • Peripartum Cardiomyopathy
  • Adriamycin induced Cardiomyopathy
  • Others (Marfan, Sarcoid, Myocarditis, Eisenmengers, Rheumatic, Valvular)
    Donors

Before you apply

Please provide the following documents at the time of requesting tissue:

1. Two-page project proposal. This proposal will need to satisfy the follow criteria:

a. the language used must targeted towards a general scientific audience

b. must justify the volume, number and types of samples required for the project

2. Two-page CV/biosketch

3. Human Research Ethics Committee (HREC) approval letter from your local institution with start and end dates

Please send these documents tosydneyheartbank@gmail.com.

Application process overview

1. Lodge a request for tissue. This must include the proposal, CV and HREC approval.

2. The documents will be assessed by members of the scientific review board.

3. If approved, the SHB will generate a Material Transfer Agreement between the two institutions.

4. The SHB will then arrange to transport the tissue in a Nitrogen Dry Shipper to a courier address.

Note: tissue is always transported via FEDEX and its return cost is the responsibility of the recipient laboratory.

Sydney Heart Bank User Policy

Any and all biological samples from the SHB must

1. always be stored in liquid nitrogen (liquid or vapour phase)

2. not be re-coded in any form

3. not be used for project other than that specified in the Human Research Ethics Committee (HREC) Approval and Material Transfer Agreements.

4. not be exchanged between institutions without pre-acknowledgement and agreement from the SHB

5. be returned to the SHB if unused

All publication outputs (including conferences) must

1. acknowledge and identify HREC approval from the Sydney Heart Bank and the recipient’s local institution

2. use the original de-identified code provided by the SHB. This information enables published data to be shared between laboratories working on tissue from the same patients.

International links

United States

(Harvard University and Brigham & Women's Hospital, Boston.) Mechanisms of Human Cardiac Regeneration.

Selected grants

2017

  • Developing experimental alternatives to animal models using human heart tissue; Lal S, Li A, Dos Remedios C; Medical Advances Without Animals/Research Grants.

2015

  • The Sydney Human Heart Bank: A resource that eliminates the use of animals in research; Dos Remedios C, King D, Lal S, Li A; Medical Advances Without Animals/Research Grants.

2014

  • MedMAP (Mobile Assessment Platform); O'Mara D, Keay K, Lal S, Rothnie I; DVC Education/Large Educational Innovation Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Mohamed, A., Lal, S., Ho, J., Brown, A., Lui, R., Nguyen, L., Yong, A., Su, Y., Braet, F., Dyer, W., Junius, F., Cumming, R., Freedman, B., Kritharides, L., Dos Remedios, C. (2010). How to interrogate the cellular immune system in patients with ischemic heart disease. In Dmitry Vukovic & Vladimir Kiyan (Eds.), Myocardial ischemia: Causes, symptoms and treatment, (pp. 195-216). United States: Nova Science Publishers.

Journals

  • Vikhorev, P., Smoktunowicz, N., Munster, A., Copeland, O., Kostin, S., Montgiraud, C., Messer, A., Toliat, M., Li, A., Dos Remedios, C., Lal, S., et al (2018). Author Correction: Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports, 8(1), 14485. [More Information]
  • Dos Remedios, C., Lal, S., Li, A., McNamara, J., Keogh, A., MacDonald, P., Cooke, R., Ehler, E., Knoll, R., Marston, S., et al (2018). Correction to: The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophysical Reviews, 10(3), 941. [More Information]
  • Lal, S., Kotchetkova, I., Cao, J., Jackson, D., Cordina, R., Celermajer, D. (2018). Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. European Journal of Heart Failure, 20(4), 812-815. [More Information]
  • Dos Remedios, C., Li, A., Lal, S. (2018). Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective. Biophysical Reviews, 10(4), 949-954. [More Information]
  • Wang, N., Fulcher, J., Abeysuriya, N., Adams, M., Lal, S. (2018). Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis. Heart, 104(6), 517-524. [More Information]
  • Lal, S. (2018). Primary Sjogren?s Syndrome. New England Journal of Medicine, 379(1), 96-97.
  • Cao, J., Lee, S., Phan, K., Celermajer, D., Lal, S. (2018). Renin-angiotensin-aldosterone inhibition improves right ventricular function: a meta-analysis. Heart Asia, 10(1), 1-7. [More Information]
  • Bagnall, R., Ingles, J., Dinger, M., Cowley, M., Ross, S., Minoche, A., Lal, S., Turner, C., Colley, A., Rajagopalan, S., Semsarian, C., et al (2018). Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 72(4), 419-429. [More Information]
  • Vikhorev, P., Smoktunowicz, N., Munster, A., Copeland, O., Kostin, S., Montgiraud, C., Messer, A., Toliat, M., Li, A., Dos Remedios, C., Lal, S., et al (2017). Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports, 7(1), 1-11. [More Information]
  • Mamidi, R., Li, J., Gresham, K., Verma, S., Doh, C., Li, A., Lal, S., Dos Remedios, C., Stelzer, J. (2017). Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium. Circulation. Heart Failure, 10(10), 1-11. [More Information]
  • Crossman, D., Shen, X., Jullig, M., Munro, M., Hou, Y., Middleditch, M., Shrestha, D., Li, A., Lal, S., Dos Remedios, C., et al (2017). Increased collagen within the transverse tubules in human heart failure. Cardiovascular Research, 113(8), 879-891. [More Information]
  • McNamara, J., Li, A., Lal, S., Bos, J., Harris, S., van der Velden, J., Ackerman, M., Cooke, R., Dos Remedios, C. (2017). MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PloS One, 12(6), 1-22. [More Information]
  • Wang, N., Lal, S. (2017). Post-dilation in transcatheter aortic valve replacement: A systematic review and meta-analysis. Journal of Interventional Cardiology, 30(3), 204-211. [More Information]
  • Dos Remedios, C., Lal, S., Li, A., McNamara, J., Keogh, A., Macdonald, P., Cooke, R., Ehler, E., Knoll, R., Marston, S., et al (2017). The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophysical Reviews, 9(4), 431-441. [More Information]
  • McNamara, J., Li, A., Smith, N., Lal, S., Graham, R., Kooiker, K., van Dijk, S., Dos Remedios, C., Harris, S., Cooke, R. (2016). Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. Journal of Molecular and Cellular Cardiology, 94, 65-71. [More Information]
  • Lal, S., Turner, L., Powell, C., Wilson, M., Bannon, P. (2016). Improvements in left ventricular ejection fraction and quality of life in patients with heart failure who undergo coronary artery bypass surgery. International Journal of Cardiology, 222, 671-673. [More Information]
  • Lal, S., Li, A., Dos Remedios, C. (2016). Limitations in Translating Animal Studies to Humans in Cardiovascular Disease. Journal of Cardiovascular Translational Research, 9(2), 165-166. [More Information]
  • Lal, S., Nguyen, L., Tezone, R., Ponten, F., Odeberg, J., Li, A., Dos Remedios, C. (2016). Tissue microarray profiling in human heart failure. Proteomics, 16(17), 2319-2326. [More Information]
  • Lal, S., Li, A., Allen, D., Allen, P., Bannon, P., Cartmill, T., Cooke, R., Farnswoirth, A., Keogh, A., Dos Remedios, C. (2015). Best practice BioBanking of human heart tissue. Biophysical Reviews, 7(4), 399-406. [More Information]
  • Ge, Z., Lal, S., Le, T., Dos Remedios, C., Chong, J. (2015). Cardiac stem cells: translation to human studies. Biophysical Reviews, 7(1), 127-139. [More Information]
  • Koopmann, T., Adriaens, M., Moerland, P., Marsman, R., Westerveld, M., Lal, S., Zhang, T., Simmons, C., Baczko, I., Dos Remedios, C., et al (2014). Genome-Wide Identification of Expression Quantitative Trait Loci (eQTLs) in Human Heart. PloS One, 9(5), 1-11. [More Information]
  • Li, A., Estigoy, C., Raftery, M., Cameron, D., Odeberg, J., Ponten, F., Lal, S., Dos Remedios, C. (2013). Heart Research Advances Using Database Search Engines, Human Protein Atlas and the Sydney Heart Bank. Heart, Lung and Circulation, 22(10), 819-826. [More Information]
  • Cahill, H., Jones, A., Herkes, R., Cook, K., Stirling, A., Halbert, T., Yates, A., Lal, S., Gardo, A., Donnelly, R., Gattas, D. (2011). Introduction of a new observation chart and education programme is associated with higher rates of vital-sign ascertainment in hospital wards. BMJ Quality and Safety, 20(9), 791-796. [More Information]
  • Wolfe, J., Ishiwata, S., Braet, F., Whan, R., Su, Y., Lal, S., Dos Remedios, C. (2011). SPontaneous Oscillatory Contraction (SPOC): auto-oscillations observed in striated muscle at partial activation. Biophysical Reviews, 3(2), 53-62. [More Information]
  • Lal, S., Dos Remedios, C. (2010). Is There a Connection between Ablation of Atrial Fibrillation and Reduced Apoptosis? Cardiology, 117(3), 161-2. [More Information]
  • Lal, S., Brown, A., Nguyen, L., Braet, F., Dyer, W., Dos Remedios, C. (2009). Using antibody arrays to detect microparticles from acute coronary syndrome patients based on Cluster of Differentiation (CD) antigen expression. Molecular and Cellular Proteomics, 8(4), 799-804. [More Information]
  • Lal, S., Lui, R., Nguyen, L., Macdonald, P., Denyer, G., Dos Remedios, C. (2004). Increases In Leukocyte Cluster Of Differentiation Antigen Expression During Cardiopulmonary Bypass In Patients Undergoing Heart Transplantation. Proteomics, 4(7), 1918-1926. [More Information]
  • Lal, S., Christopherson, R., Dos Remedios, C. (2002). Antibody arrays: an embryonic but rapidly growing technology. Drug Discovery Today, 7(18 Supplement), S143-S149. [More Information]

2018

  • Vikhorev, P., Smoktunowicz, N., Munster, A., Copeland, O., Kostin, S., Montgiraud, C., Messer, A., Toliat, M., Li, A., Dos Remedios, C., Lal, S., et al (2018). Author Correction: Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports, 8(1), 14485. [More Information]
  • Dos Remedios, C., Lal, S., Li, A., McNamara, J., Keogh, A., MacDonald, P., Cooke, R., Ehler, E., Knoll, R., Marston, S., et al (2018). Correction to: The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophysical Reviews, 10(3), 941. [More Information]
  • Lal, S., Kotchetkova, I., Cao, J., Jackson, D., Cordina, R., Celermajer, D. (2018). Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. European Journal of Heart Failure, 20(4), 812-815. [More Information]
  • Dos Remedios, C., Li, A., Lal, S. (2018). Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective. Biophysical Reviews, 10(4), 949-954. [More Information]
  • Wang, N., Fulcher, J., Abeysuriya, N., Adams, M., Lal, S. (2018). Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis. Heart, 104(6), 517-524. [More Information]
  • Lal, S. (2018). Primary Sjogren?s Syndrome. New England Journal of Medicine, 379(1), 96-97.
  • Cao, J., Lee, S., Phan, K., Celermajer, D., Lal, S. (2018). Renin-angiotensin-aldosterone inhibition improves right ventricular function: a meta-analysis. Heart Asia, 10(1), 1-7. [More Information]
  • Bagnall, R., Ingles, J., Dinger, M., Cowley, M., Ross, S., Minoche, A., Lal, S., Turner, C., Colley, A., Rajagopalan, S., Semsarian, C., et al (2018). Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 72(4), 419-429. [More Information]

2017

  • Vikhorev, P., Smoktunowicz, N., Munster, A., Copeland, O., Kostin, S., Montgiraud, C., Messer, A., Toliat, M., Li, A., Dos Remedios, C., Lal, S., et al (2017). Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports, 7(1), 1-11. [More Information]
  • Mamidi, R., Li, J., Gresham, K., Verma, S., Doh, C., Li, A., Lal, S., Dos Remedios, C., Stelzer, J. (2017). Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium. Circulation. Heart Failure, 10(10), 1-11. [More Information]
  • Crossman, D., Shen, X., Jullig, M., Munro, M., Hou, Y., Middleditch, M., Shrestha, D., Li, A., Lal, S., Dos Remedios, C., et al (2017). Increased collagen within the transverse tubules in human heart failure. Cardiovascular Research, 113(8), 879-891. [More Information]
  • McNamara, J., Li, A., Lal, S., Bos, J., Harris, S., van der Velden, J., Ackerman, M., Cooke, R., Dos Remedios, C. (2017). MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PloS One, 12(6), 1-22. [More Information]
  • Wang, N., Lal, S. (2017). Post-dilation in transcatheter aortic valve replacement: A systematic review and meta-analysis. Journal of Interventional Cardiology, 30(3), 204-211. [More Information]
  • Dos Remedios, C., Lal, S., Li, A., McNamara, J., Keogh, A., Macdonald, P., Cooke, R., Ehler, E., Knoll, R., Marston, S., et al (2017). The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophysical Reviews, 9(4), 431-441. [More Information]

2016

  • McNamara, J., Li, A., Smith, N., Lal, S., Graham, R., Kooiker, K., van Dijk, S., Dos Remedios, C., Harris, S., Cooke, R. (2016). Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. Journal of Molecular and Cellular Cardiology, 94, 65-71. [More Information]
  • Lal, S., Turner, L., Powell, C., Wilson, M., Bannon, P. (2016). Improvements in left ventricular ejection fraction and quality of life in patients with heart failure who undergo coronary artery bypass surgery. International Journal of Cardiology, 222, 671-673. [More Information]
  • Lal, S., Li, A., Dos Remedios, C. (2016). Limitations in Translating Animal Studies to Humans in Cardiovascular Disease. Journal of Cardiovascular Translational Research, 9(2), 165-166. [More Information]
  • Lal, S., Nguyen, L., Tezone, R., Ponten, F., Odeberg, J., Li, A., Dos Remedios, C. (2016). Tissue microarray profiling in human heart failure. Proteomics, 16(17), 2319-2326. [More Information]

2015

  • Lal, S., Li, A., Allen, D., Allen, P., Bannon, P., Cartmill, T., Cooke, R., Farnswoirth, A., Keogh, A., Dos Remedios, C. (2015). Best practice BioBanking of human heart tissue. Biophysical Reviews, 7(4), 399-406. [More Information]
  • Ge, Z., Lal, S., Le, T., Dos Remedios, C., Chong, J. (2015). Cardiac stem cells: translation to human studies. Biophysical Reviews, 7(1), 127-139. [More Information]

2014

  • Koopmann, T., Adriaens, M., Moerland, P., Marsman, R., Westerveld, M., Lal, S., Zhang, T., Simmons, C., Baczko, I., Dos Remedios, C., et al (2014). Genome-Wide Identification of Expression Quantitative Trait Loci (eQTLs) in Human Heart. PloS One, 9(5), 1-11. [More Information]

2013

  • Li, A., Estigoy, C., Raftery, M., Cameron, D., Odeberg, J., Ponten, F., Lal, S., Dos Remedios, C. (2013). Heart Research Advances Using Database Search Engines, Human Protein Atlas and the Sydney Heart Bank. Heart, Lung and Circulation, 22(10), 819-826. [More Information]

2011

  • Cahill, H., Jones, A., Herkes, R., Cook, K., Stirling, A., Halbert, T., Yates, A., Lal, S., Gardo, A., Donnelly, R., Gattas, D. (2011). Introduction of a new observation chart and education programme is associated with higher rates of vital-sign ascertainment in hospital wards. BMJ Quality and Safety, 20(9), 791-796. [More Information]
  • Wolfe, J., Ishiwata, S., Braet, F., Whan, R., Su, Y., Lal, S., Dos Remedios, C. (2011). SPontaneous Oscillatory Contraction (SPOC): auto-oscillations observed in striated muscle at partial activation. Biophysical Reviews, 3(2), 53-62. [More Information]

2010

  • Mohamed, A., Lal, S., Ho, J., Brown, A., Lui, R., Nguyen, L., Yong, A., Su, Y., Braet, F., Dyer, W., Junius, F., Cumming, R., Freedman, B., Kritharides, L., Dos Remedios, C. (2010). How to interrogate the cellular immune system in patients with ischemic heart disease. In Dmitry Vukovic & Vladimir Kiyan (Eds.), Myocardial ischemia: Causes, symptoms and treatment, (pp. 195-216). United States: Nova Science Publishers.
  • Lal, S., Dos Remedios, C. (2010). Is There a Connection between Ablation of Atrial Fibrillation and Reduced Apoptosis? Cardiology, 117(3), 161-2. [More Information]

2009

  • Lal, S., Brown, A., Nguyen, L., Braet, F., Dyer, W., Dos Remedios, C. (2009). Using antibody arrays to detect microparticles from acute coronary syndrome patients based on Cluster of Differentiation (CD) antigen expression. Molecular and Cellular Proteomics, 8(4), 799-804. [More Information]

2004

  • Lal, S., Lui, R., Nguyen, L., Macdonald, P., Denyer, G., Dos Remedios, C. (2004). Increases In Leukocyte Cluster Of Differentiation Antigen Expression During Cardiopulmonary Bypass In Patients Undergoing Heart Transplantation. Proteomics, 4(7), 1918-1926. [More Information]

2002

  • Lal, S., Christopherson, R., Dos Remedios, C. (2002). Antibody arrays: an embryonic but rapidly growing technology. Drug Discovery Today, 7(18 Supplement), S143-S149. [More Information]

To update your profile click here. For support on your academic profile contact .